Navigation Links
Coulter in Medical News

Upcoming Beckman Coulter Investor Events Second Half of 2009

ORANGE COUNTY, Calif., July 8 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announces upcoming company presentations and investor events. Please mark your...

Beckman Coulter to Present at the 2009 Goldman Sachs Healthcare Conference

ORANGE COUNTY, Calif., May 29 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Allan Harris, Beckman Coulter's vice president of strateg...

Beckman Coulter Pending Acquisition of Olympus Diagnostics Systems Passes Milestone with U.S. Regulatory Approval

ORANGE COUNTY, Calif., May 13 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, today announced that the Federal Trade Commission has terminated its review un...

Beckman Coulter Announces First in Series of Flow Cytometry Product Introductions for 2009

Gallios(TM) Flow Cytometry System Offers New Standard of Performance for Researchers ORANGE COUNTY, Calif., March 12 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, and manufacturer of products that simplify and automate complex biomedical testing, announc...

Beckman Coulter to Present at Upcoming Healthcare Conferences

ORANGE COUNTY, Calif., March 9 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Charlie Slacik, Beckman Coulter's Senior Vice President ...

Beckman Coulter Announces Third Quarter 2008 Results

Revenue Increases 13.4% On Target to Achieve Full Year Earnings Outlook ORANGE COUNTY, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer and marketer of products that simplify, automate and innova...

Beckman Coulter to Present at the Morgan Stanley Global Healthcare Unplugged Conference

ORANGE COUNTY, Calif., April 21 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Scott Garrett, Beckman Coulter's chairman, president...

Beckman Coulter Announces First Quarter 2008 Earnings to be Released on Wednesday, April 30, 2008, Before Market Opens

Conference Call Scheduled for 8:30 a.m. ET ORANGE COUNTY, Calif., April 11 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today it will host a conference call on Wednesday, April 30, 2008, at 8:30 a.m. ET to discuss the company's first quarter 2008 resul...

Beckman Coulter to Present at the 2007 RBC Capital Markets Healthcare Conference

FULLERTON, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Scott Garrett, Beckman Coulter's president and chief execu...

Beckman Coulter to Acquire Flow Cytometry Instrumentation Business From Dako

Highly-Regarded Research Flow Cytometry Portfolio Targeted at Fast Growing Market Segment FULLERTON, Calif., and GLOSTRUP, Denmark, Nov. 19 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer of products that simplify and automate comp...
Coulter in Medical Products

Streck-Kleen Enzymatic Cleanser

Description:... automated and semi-automated hematology instruments, including the Coulter® Counters. The 475ml bottle has a flip-top spout for convenient use on coulter MD Series instruments that require manual addition of an enzyme cleaner. Maximum enzyme activity is a feature of this product. The shelf life of Strec...
Company:Streck

Retic-Chex Linearity Control

Description:...f the system. Retic-Chex Linearity is available in five-vial sets with values assigned for Abbott CELL-DYN 3200, 3500, 3700 and 4000; Bayer ADVIA 120; coulter STKS, MAXM, HmX, GENS and LH 750/LH 755; Sysmex R-3000, R-3500, R-1000, RAM-1, XE-2100 and XT-2000i. Open-vial stability is five days and closed-vial ...
Company:Streck

nRBC-Chex for LH nRBC Control

Description:... blood cell (nRBC) control for evaluating the accuracy and precision of the coulter LH 750/LH 755 hematology analyzer in its enumeration of the nRBC parameter. The assay provides for the coulter LH 750/LH 755. nRBC-Chex for LH is a two-level control packaged in plastic,...
Company:Streck

Para 12 Whole Blood Hematology Control, Three-part Differential

Description:... Para 12 is a three-part differential control assayed for all parameters on the coulter S Series, STKR, J Series, T Series, AcT/AcT diff/AcT diff2, MD Series and ONYX Series; Abbott CELL-DYN 1400, 1500, 1600, 1700, and 1800; Danam Datacel...
Company:Streck

Para 12 Extend Whole Blood Hematology Control, Three-part Differential

Description:... Para 12 Extend is a three-part differential control assayed for all parameters on the coulter S Series, STKR, J Series, T Series, AcT/AcT diff/AcT diff2, MD Series and ONYX Series; Abbott CELL-DYN 1400, 1500, 1600, 1700, and 1800; ABX Micros 60...
Company:Streck

Para 5X Whole Blood Hematology Control, Five-part Differential

Description:... Para 5X is a whole blood hematology control manufactured specifically for the ABX Pentra 60C+, 80 and 120, and the coulter AcT5diff instruments. The composition of this product offers a unique white cell differential, positioning the populations within the limitations of t...
Company:Streck

STaK-Chex Plus Retics 5-Part Differential Control

Description:... STaK-Chex Plus Retics is a 5-part differential control that controls all parameters, including reticulocytes, for the coulter GENS, STKS, LH 750/LH 755, MAXM and HmX instruments. The assay contains automated and manual reticulocyte values for all three levels. White blood cel...
Company:Streck

Cell-Chex Auto Automated Body Fluid Cell Count Control

Description:... blood cell counts in patient body fluid samples. The assay provides total RBC and WBC values for the Abbott CELL-DYN 3200, 4000 and Sapphire, Beckman coulter LH750/LH 755 (levels 2 and 3 only) and Sysmex XE-2100 instruments. Cell-Chex Auto is a three-level control packaged in a plastic 76mm vial with a pier...
Company:Streck

STaK-Chex White Cell Differential Control

Description:... STaK-Chex, a whole blood assayed hematology control, offers complete assay values for the five-part white cell differential available with the coulter GENS, STKS, MAXM and HmX. This unique product has 14-day open-vial stability, 105-day closed-vial stability and is available in low, normal and high l...
Company:Streck

ICON 25 hCG Test

Description:... In pregnancy testing, our new ICON 25 hCG test will reshape your thinking. It gives you fast, accurate results, plus Beckman coulter confidence. For the physician's office, ICON 25 hCG offers CLIA waived simplicity for urine and a "moderately complex" catergorization for serum. For ...
Company:Beckman Coulter, Inc

More>>

Coulter in Biological News

Beckman Coulter Updates 2008 Outlook

ORANGE COUNTY, Calif., Dec. 15 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, reaffirms 2008 outlook and provides preliminary 2009 financial outlook. ...

Yu receives research funding from the Wallace H. Coulter Foundation

HOBOKEN, N.J. -- Stevens Institute of Technology Professor Xiaojun Yu, Ph.D., has received an Early Career Translational Research Award in Biomedical Engineering from the Wallace H. Coulter Foundation. This award will support his research titled, Novel structured nanofibrous scaffolds for bone hea...

New center at Georgia Tech aims to improve recovery of soldiers with severe injuries

...from the wars the United States is fighting," said center director Barbara Boyan, the Price Gilbert, Jr. Chair in Tissue Engineering at the Wallace H. coulter Department of Biomedical Engineering at Georgia Tech and Emory University. The center will leverage the expertise of Georgia Tech researchers in mu...

New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome

...rmines effectiveness," said Ravi Bellamkonda, a professor in the Wallace H. coulter Department of Biomedical Engineering at Georgia Tech and Emory University. ...dose of a wide range of breast cancer chemotherapeutics. Bellamkonda and coulter Department postdoctoral fellow Efstathios Karathanasis collaborated on this...

Preventing soil erosion in continuous corn

...soils with abundant rainfall, the authors, Jeffrey coulter of the University of Minnesota and Emerson Nafzige... productive environments in the central Corn Belt, coulter says that "no-till continuous corn may be less app...s a corn cropping systems agronomist in Minnesota, coulter believes that strip-till continuous corn might be ...

Researchers create new class of fluorescent dyes to detect reactive oxygen species in vivo

...iren Murthy, assistant professor in the Wallace H. coulter Department of Biomedical Engineering at Georgia Te... also simple and quick to synthesize, according to coulter Department postdoctoral fellow Kousik Kundu. Sodiu... minutes. W. Robert Taylor, a professor in the coulter Department and Emory's Division of Cardiology, and...

'Strained' quantum dots show new optical properties

...neration of quantum dots had optical properties that could be tuned by their size," says senior author Shuming Nie, PhD, a professor in the Wallace H. coulter Department of Biomedical Engineering at Georgia Tech and Emory University. "We have discovered another way to tune quantum dots' properties: by modula...

Drug-embedded microparticles bolster heart function in animal studies

... the right time -- is more challenging than simply swallowing an aspirin, says senior author Michael Davis, PhD, assistant professor in the Wallace H. coulter Department of Biomedical Engineering at Georgia Tech and Emory University. "If you look at previous studies to see what it would take to get enough...

Researchers develop new self-training gene prediction program for fungi

...de fungal genes," added Borodovsky, who is also a Regents' Professor in the coulter Department of Biomedical Engineering and the Computational Science and Engi...esearch team included graduate student Vardges Ter-Hovhannisyan, Wallace H. coulter Department of Biomedical Engineering research scientist Alexandre Lomsadze ...

Prosthetic vein valve designed to direct blood flow shows promising pre-clinical results

...t the Society for Biomaterials Fall Symposium in Atlanta on September 12. The research under way for the past five years is funded by the Wallace H. coulter Foundation and the National Collegiate Inventors and Innovators Alliance. Ku's collaborators on this project include Rudy Gleason, an assistant pro...
Coulter in Biological Technology

Beckman Coulter Completes Acquisition of Olympus' Lab-Based Diagnostics Business

ORANGE COUNTY, Calif., Aug. 2 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today the completion of the acquisition of Olympus' lab-based dia...

Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share

ORANGE COUNTY, Calif., July 27 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today that its Board of Directors declared a quarterly dividend payout of seventeen cents ($0.17) per share of outstanding common stock, payable on August 24, 2009 to all sto...

Beckman Coulter Prices $500 Million Senior Notes Offering

ORANGE COUNTY, Calif., May 18 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today the pricing of its senior notes offering of: ...

Beckman Coulter to Present at the Bank of America and Merrill Lynch Healthcare Conference

ORANGE COUNTY, Calif., May 8 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Scott Garrett, Beckman Coulter's chairman, president and c...

Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share

ORANGE COUNTY, Calif., April 28 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today that its Board of Directors declared a quarterly dividend payout of seventeen cents ($0.17) per share of outstanding common stock, payable on May 22, 2009 to all stockholders of record on...

Beckman Coulter Announces First Quarter 2009 Results

Reaffirms Full Year Outlook ORANGE COUNTY, Calif., April 28 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today first quarter ended March 3...

Beckman Coulter Announces First Quarter 2009 Earnings to be Released on Tuesday, April 28, 2009, After Market Closes

Conference Call Scheduled for 5:00 p.m. ET ORANGE COUNTY, Calif., April 13 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today it will host a conference call on Tuesday, April 28, 2009, at 5:00 p.m. ET to discuss the company's first quarter 2009 results. Earnings w...

Beckman Coulter to Webcast Annual Stockholders' Meeting

FULLERTON, Calif., April 10 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, will webcast its Annual Stockholders' Meeting on Thursday, April 23, 2009, begin...

Beckman Coulter to Acquire Lab-Based Diagnostics Business From Olympus Corporation

- Expands Beckman Coulter's Worldwide Position in Clinical Chemistry - Complementary Market Positions and Product Portfolios in Chemistry and Automation Broaden Global Opportunity, Increase Customer Choice - Penetration of Beckman Coulter's Immunoassay Products into Olympus' Installe...

Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals

ORANGE COUNTY, Calif., Feb. 9 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, announced today fourth quarter and year ended December 31, 2008 results. For ...
Coulter in Biological Products

DU 530 Life Science UV/Visible Spectrophotometers from Beckman Coulter

Description: ...
Company:Beckman Coulter

DU 530 Life Science UV/Visible Spectrophotometers from Beckman Coulter

Description: ...
Company:Beckman Coulter

P/ACE™ MDQ Molecular Characterization System from Beckman Coulter

Description: ...
Company:Beckman Coulter

N5 Submicron Particle Size Analyzer - 115V from Beckman Coulter

Description: If particles in the submicron range are part of your production or product development process, measurement and control of particle size is important to you. You need an analyzer that can reliably detect the component populations in your sample every time. The N5 Submicron Particle Size Analyzer us...
Company:Beckman Coulter

N5 Submicron Particle Size Analyzer - 230V from Beckman Coulter

Description: If particles in the submicron range are part of your production or product development process, measurement and control of particle size is important to you. You need an analyzer that can reliably detect the component populations in your sample every time. The N5 Submicron Particle Size Analyzer us...
Company:Beckman Coulter

Biomek FX Laboratory Workstation (High Throughput) from Beckman Coulter

Description: ...
Company:Beckman Coulter

Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter

Description: ...
Company:Beckman Coulter

Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter

Description: ...
Company:Beckman Coulter

CELL LAB QUANTA* Flow Cytometer from Beckman Coulter

Description: The Cell Lab Quantas unique combination of Coulter volume and fluorescence provides unsurpassed population resolution capabilities and accurate cell counting. This flow cytometer has multiple excitation wavelengths, including UV, allowing flexible fluorochrome selection for a variety of multi-color...
Company:Beckman Coulter

Cytomics FC 500 Series Flow Cytometry Systems from Beckman Coulter

Description: The Cytomics FC 500 Series is a sophisticated product family equipped with the most advanced technologies available. The FC 500 Series delivers flexible testing, powerful software and a user-friendly interface features that help researchers optimize their overall workflow efficiency while maintaini...
Company:Beckman Coulter

More>>

Coulter in Biological Dictionary

Somatic hypermutation

...y in B and T lymphocytes. ... InVivoScribe Product Group - IGH Somatic Hypermutation . ... IGH Somatic Hypermutation Assay MegaKit- Beckman coulter CE / NAT Platforms. 5-101-0022 ... Somatic hypermutation of Ig genes is probably dependent on transcription of the ... In this study, we have...

Flow cytometry

...er-reviewed publications with data obtained from Quanta Flow Cytometry Systems ... Cell Lab Quanta™ SC - Advanced Flow Cytometry with 3-Color, coulter Volume and ... What is Flow Cytometry ? Flow cytometry , typically using fluorescent probes ... For cell purification, flow cytometry i...
Other Tags
(Date:8/20/2014)... GA (PRWEB) August 20, 2014 ... to healthcare, Jvion successfully predicted stage iii and ... that, in some situations, approached 90%. A company ... been achieved in commercial or academic settings. The ... prevent all types of hospital-acquired conditions to help ...
(Date:8/20/2014)... Oshkosh, Wisconsin (PRWEB) August 20, 2014 ... to the general public at fair prices. The well-known ... ability, and she is now touring in 19 cities, ... locations where the television personality will visit are Albany, ... Kalamazoo, Colorado Springs, Albuquerque, Beverly Hills and San Diego. ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Blaine ... the innovative RevitaDERM® Psoriasis Treatment to ... associated with psoriasis. This all-in-one product was created ... RevitaDERM® Psoriasis Treatment is powered by coal tar ... associated with this effective ingredient. , RevitaDERM® ...
(Date:8/20/2014)... August 20, 2014 The “Human ... Acting, Intermediate Acting, Premixed), Modern Human Insulin (Rapid ... Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast to ... drivers,restraints, challenges, opportunities, current market trends,and strategies impacting ... estimates and forecasts of the revenue and share ...
(Date:8/20/2014)... 20, 2014 AttorneyOne.com, a recognized authority on ... from the FDA on Sodium Chloride IV . ... lot of Sodium Chloride IV 0.9%, USP 1000 mL, by ... presence of particulate matter. Sodium Chloride Injection, USP is used ... priming solution in hemodialysis procedures. , The reason ...
Breaking Medicine News(10 mins):Health News:Jvion Achieves Benchmark Accuracy in Pressure Ulcer Prediction 2Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2Health News:RevitaDERM® Psoriasis Treatment Now Available At Over 7,600 CVS/pharmacies 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market by Product Types and Brand Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Sodium Chloride IV 0.9% by Baxter Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2
(Date:8/19/2014)... the world, leprosy and tuberculosis live side-by-side. Worldwide ... per year, with nearly all of them occurring ... vaccine Bacille Calmette-Guerin, or BCG, provides only partial ... more potent vaccine is needed to combat both ... weapon against both diseases., In a study published ...
(Date:8/19/2014)... a biomarker strongly associated with basal-like breast cancer, ... many types of chemotherapy. The biomarker, a protein ... therapeutics designed to treat this often deadly cancer. ... The Cancer Genome Atlas, molecular biologists Curt M. ... and bioinformatics techniques to detect patterns of gene ...
(Date:8/19/2014)... crocodiles colonised the seas during warm phases and became ... study which establishes a link between marine crocodilian diversity ... of more than 140 million years. , The ... de Lyon, France and formerly from the University of ... Communications ., Today, crocodiles are ,cold-blooded, animals that mainly ...
Breaking Biology News(10 mins):New vaccine shows promise as stronger weapon against both tuberculosis and leprosy 2Biomarker in an aggressive breast cancer is identified 2Biomarker in an aggressive breast cancer is identified 3Evolution of marine crocodilians constrained by ocean temperatures 2
Other Contents